LON:AZN - AstraZeneca Stock Price, News, Headlines & Rumors

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca announced a dividend on Thursday, July 26th. Stockholders of record on Thursday, August 9th will be given a dividend of GBX 68.40 per share on Monday, September 10th. This represents a dividend yield of 1.19%. The ex-dividend date is Thursday, August 9th. The official announcement can be seen at this link. View AstraZeneca's Dividend History.

23 brokerages have issued 12-month price targets for AstraZeneca's stock. Their forecasts range from GBX 4,080 to GBX 6,600. On average, they expect AstraZeneca's stock price to reach GBX 5,665.33 in the next twelve months. This suggests that the stock has a possible downside of 4.6%. View Analyst Price Targets for AstraZeneca.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 7 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Some companies that are related to AstraZeneca include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), BEXIMCO PHARMAC/S GDR REGS (BXP), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC).

Media coverage about AZN stock has been trending somewhat positive on Thursday, Accern Sentiment Analysis reports. The research group rates the sentiment of press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. AstraZeneca earned a news impact score of 0.20 on Accern's scale. They also assigned news stories about the biopharmaceutical company an impact score of 45.20 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View Recent Headlines for AstraZeneca.

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 5,936.

AstraZeneca has a market capitalization of £61.66 billion.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.